daunorubicin has been researched along with Leukemia P388 in 140 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 94 (67.14) | 18.7374 |
1990's | 42 (30.00) | 18.2507 |
2000's | 2 (1.43) | 29.6817 |
2010's | 2 (1.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, N; Blake, C; Broadhurst, MJ; Bushnell, DJ; Hartmann, HR; Hassall, CH; Keech, E; Stratton, AR; Thomas, GJ | 1 |
Israel, M; Potti, G | 1 |
Acton, EM; Fujiwara, AN; Mosher, CW; Wu, HY | 1 |
Kuhlmann, KF; Mosher, CW | 1 |
Bontemps-Gracz, M; Borowski, E; Dzieduszycka, M; Martelli, S; Stefańska, B; Tarasiuk, J | 1 |
Goncharova, SA; Konovalova, NP; Raevskaya, TA; Vystorop, IV | 1 |
Balakina, AA; Goncharova, SA; Mumyatova, VA; Pavlov, VS; Raevskaya, TA; Terent'ev, AA | 1 |
Bevilacqua, C; Boiocchi, M; Franceschin, A; Toffoli, G | 1 |
Kessel, D; Wilberding, C | 5 |
Danø, K; Nissen, NI; Skovsgaard, T | 1 |
Gabbay, EJ; Pearce, SW; Wilson, WD; Yen, SF | 1 |
Dederer, LIu; Gorbacheva, LB | 1 |
Barzi, AM; Lepri, E; Menconi, E | 1 |
Alexander, J; Khanna, I; Lednicer, D; Mitscher, LA; Veysoglu, T; Wielogorski, Z; Wolgemuth, RL | 1 |
Ganapathi, R; Grabowski, D; Riegler, F; Rouse, W | 1 |
Ivanova, LE; Khanykova, OK; Kozinets, GI; Kuznetsova, TV; Rudneva, NA | 1 |
Gambetta, R; Giuliani, F; Pezzoni, G; Savi, G; Supino, R; Tinelli, S; Zunino, F | 1 |
Volkolupova, OP | 1 |
Horton, D; Priebe, W; Varela, O | 2 |
Dawson, KM | 1 |
Karanes, C; Kessel, D; Ratanatharathorn, V; Wilberding, C | 1 |
Fukui, M; Inaba, M; Nagashima, K; Sakurai, Y; Yanagi, Y | 1 |
Fox, BW; McGown, AT; Ward, TH | 1 |
Fuks, Z; Gatt, S; Glaubiger, D; Ramu, A | 1 |
Iwanik, MJ; Ledwith, BJ; Shaw, JM; Shaw, KV; Yanovich, S | 1 |
Preston, L; Yanovich, S | 1 |
Preston, L; Shaw, JM; Yanovich, S | 1 |
Taub, RN; Yanovich, S | 1 |
Casazza, AM; Di Marco, A; Giuliani, F; Pratesi, G | 1 |
Chou, TH; Kessel, D | 1 |
Arcamone, F; Cassinelli, G; Di Matteo, F; Forenza, S; Ripamonti, MC; Ruggieri, D; Vigevani, A | 1 |
Elrod, DW; Houser, DJ; Richard, FA; Wiley, PF | 1 |
Dasdia, T; Gambetta, R; Giuliani, F; Savi, G; Zunino, F | 1 |
Acton, EM; Tong, GL | 1 |
Casazza, AM; DiMarco, A; Formelli, F; Pratesi, G; Zunino, F | 1 |
Fujikura, R; Inaba, M; Sakurai, Y | 1 |
Hasegawa, H; Inouye, Y; Kasai, R; Matsumiya, S; Sung, JH; Uchiyama, M; Yamasaki, K | 1 |
Gollapudi, S; Gupta, S; Patel, K; Singh, H | 1 |
Gollapudi, S; Gupta, S; Soni, V; Thadepalli, H | 1 |
Boesch, D; Grassberger, MA; Jachez, B; Loor, F | 1 |
Kessel, D; Woodburn, K | 1 |
Demidova, NS; Goncharova, SA; Konovalova, NP; Shiriaeva, OA | 3 |
Aleu, J; Canaves, JM; Castanys, S; Ferragut, JA; Ferrer-Montiel, AV; Gamarro, F; Gonzalez-Ros, JM; Planells-Cases, R; Soto, F | 1 |
Boesch, D; Loor, F | 1 |
Boesch, D; Emmer, G; Jachez, B; Loor, F | 1 |
Decker, D; Kessel, D; Sykes, E; Woodburn, K | 1 |
Bernaki, PD; Leont'eva, OV; Olsuf'eva, EN; Pera, P; Povarov, LS; Preobrazhenskaia, MN; Salimova, EI | 1 |
Fernández Puentes, JL; García Grávalos, MD; Quesada, AR | 1 |
Il'nitskaia, SI; Kaledin, VI | 1 |
Ayesh, S; Lan, LB; Lyubimov, E; Pashinsky, I; Stein, WD | 1 |
Algour, N; Ayesh, S; Lyubimov, E; Stein, WD | 1 |
Ayesh, S; Shao, YM; Stein, WD | 1 |
Gollapudi, S; Gupta, S; Kim, CH; Sangha, S; Tran, BN | 1 |
Chang, MS; Kobayashi, N; Lim, GJ; Takagi, Y; Tsuchiya, T | 1 |
Chuah, SK; Gollapudi, S; Hanna, N; Rana, G; Reddy, U; Thadepalli, H | 1 |
Broggini, M; Damia, G; Geroni, C; Marchini, S; Marsiglio, A; Pennella, G; Ripamonti, M | 1 |
Acton, EM; Henry, DW; Mosher, CW; Smith, TH; Tong, GL | 1 |
Bachur, NR; Clawson, RE; Egorin, MJ; Ross, LA; Schlossberger, NM | 1 |
Horton, D; Nickol, RG; Weckerle, W; Winter-Mihaly, E | 1 |
Ataullakhanov, FI; Kovaleva, VL; Mironova, SB; Vitvitsky, VM | 1 |
Gollapudi, S; Gupta, S; Jain, V; Patel, K | 1 |
Goncharova, SA; Konovalova, NP; Semenova, NA; Shiryaeva, OA; Sibeldina, LA | 1 |
Canaves, JM; Ferragut, JA; Gonzalez-Ros, JM; Soto, F | 1 |
Kessel, D | 3 |
Ferragut, JA; García-Segura, LM; Gonzalez-Ros, JM; Planells-Cases, R; Soto, F | 1 |
Ferragut, JA; Ferrer-Montiel, AV; Gonzalez-Ros, JM | 1 |
Chojnowski, G; Kriegler, AB; Linsenmeyer, ME; Nink, V; Sawyer, WH; Webster, LK; Woodcock, DM | 1 |
Chernova, OB; Demidova, NS; Goncharova, AS; Kopnin, BP; Siyanova, EY | 1 |
Bogusová, TA; Hrdina, R; Kunová, A; Kvĕtina, J | 1 |
Escriba, PV; Ferragut, JA; Ferrer-Montiel, AV; García-Segura, LM; Gonzalez-Ros, JM | 1 |
Gol'dberg, LE; Iudina, OI; Olsuf'eva, EN; Povarov, LS; Shepelevtseva, NG; Tarasova, VE; Ul'ianova, LA | 1 |
Baker, RM; Bartels, CJ; Beehler, BC; Gessner, T; Vaughan, LA | 1 |
Arakawa, M; Ekimoto, H; Nagahata, T; Takahashi, K; Uchida, T | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Tsukagoshi, S; Yamada, Y | 1 |
Capranico, G; Kohn, KW; Pommier, Y; Zunino, F | 1 |
Escriba, PV; Ferragut, JA; Ferrer-Montiel, AV; Gonzalez-Ros, JM | 1 |
Brusentsov, NA; Glazkova, TIu; Iavorskaia, NP; Iurchenko, NIa | 1 |
Fox, BW; McGown, AT | 1 |
Litinskaia, LL; Ogloblina, TA; Shestova, OL | 1 |
Bakina, EV; Glazkova, TIu; Iurchenko, GI; Lazhko, EI; Obidniak, NA; Orlova, GI; Povarov, LS; Preobrazhenskaia, MN; Zhukova, OS | 1 |
Averbuch, SD; Bachur, NR; Clawson, RE; Felsted, RL | 1 |
Fuska, J; Fusková, A; Podojil, M; Prikrylová, V; Sturdíková, M | 1 |
Aldrich, MB; Chan, PK; Yung, BY | 1 |
Adams, WJ; Brewer, JE; Dalm, EA; Hosley, JD; McGovren, JP | 1 |
Bodley, A; Giuliani, FC; Israel, M; Kirschenbaum, S; Koseki, Y; Liu, LF; Potmesil, M; Seshadri, R; Silber, R | 1 |
Buhl-Jensen, P; Sehested, M; Simpson, D; Skovsgaard, T | 1 |
Jonker, R; Nooter, K; Oostrum, R; Stokdijk, W; van Dekken, H; van den Engh, G | 1 |
Goncharova, SA; Konovalova, NP; Semenova, NA; Shiriaeva, OA; Sibel'dina, LA | 1 |
Lukacs, G; Olesker, A; Rocherolle, V | 1 |
Kawai, H; Komeshima, N; Nakajima, S; Otake, N; Takeuchi, T; Tsuruo, T; Watanabe, M | 1 |
Fang, WD; Warrington, RC | 1 |
Ganapathi, R; Grabowski, D; Israel, M; Schmidt, H; Seshadri, R | 1 |
Capizzi, RL; Chandrasekaran, B; Dimling, J | 1 |
Fiallo, MM; Garnier-Suillerot, A | 2 |
Crooke, ST; Faucette, LF; Johnson, RK; McCabe, FL; Mirabelli, CK; Sung, CM | 1 |
Inaba, M; Nagashima, K | 1 |
Bontemps-Gracz, M; Borowski, E; Dzieduszycka, M; Martelli, S; Stefańska, B | 1 |
Sehested, M; Skovsgaard, T; van Deurs, B; Winther-Nielsen, H | 1 |
Fox, BW; McGown, A; Poppitt, DG | 1 |
Futch, WS; Iwanik, M; Rosowsky, A; Schook, LB; Shaw, JM; Shaw, KV; Yanovich, S | 1 |
Murray, SL; Slater, LM; Stupecky, M; Sweet, P; Wetzel, MW | 1 |
Iida, H; Tsuruo, T | 1 |
Krishan, A | 1 |
Havlick, MJ; Jackson, RC; Klohs, WD; Steinkampf, RW | 1 |
Capranico, G; Soranzo, C; Zunino, F | 1 |
Averbuch, SD; Felsted, RL; Glover, CJ | 1 |
Inaba, M | 1 |
Capranico, G; Dasdia, T; Riva, A; Tinelli, S; Zunino, F | 1 |
Fizames, C | 1 |
Kuśnierczyk, H; Radzikowski, C; Rak, J | 1 |
Demidova, NS; Goncharova, SA; Konovalova, NP; Shevtsova, VN; Shiriaeva, OA | 1 |
Hait, WN; Palayoor, ST; Stein, JM | 1 |
Chernova, OB; Demidova, NS; Goncharova, SA; Gudkov, AV; Kopnin, BP | 1 |
Ganapathi, R; Grabowski, D; Schmidt, H; Turinic, R; Valenzuela, R; Yen, A | 1 |
Joneckis, CC; Ross, DD; Schiffer, CA | 1 |
Dvortsák, P; Kuszmann, J; Medgyes, G; Tory, K | 1 |
Borowski, E; Dzieduszycka, M; Martelli, S; Stefanska, B | 1 |
Fisher, J; Ramakrishnan, K | 1 |
Acton, EM; Filppi, JA; Taylor, DL; Tong, GL; Wolgemuth, RL | 1 |
Filppi, JA; Gill, H; Mitscher, LA; Wolgemuth, RL | 1 |
Kimura, Y; Matsumoto, T; Ohsaki, M; Suzuki, M; Terashima, S | 2 |
Israel, M; Potti, PG; Seshadri, R | 1 |
Bukowski, R; Fishleder, A; Ganapathi, R; Grabowski, D; Gulick, P; Miller, R; Turinic, R; Valeunzuela, R | 1 |
Gordon, K; Krishan, A; Sauerteig, A; Swinkin, C | 1 |
Ivanova, LE; Khanykova, OK; Kozinets, GI; Kuznetsova, TV | 1 |
Fizames, C; Imbach, JL; Lavelle, F; Lukacs, G; Olesker, A; Ponsinet, G; Thang, TT | 1 |
Cheung, TM; Horton, D; Priebe, W; Turner, WR; Weckerle, W | 1 |
Ivanova, E; Khanykova, OK; Kozinets, GI; Kuznetsova, TV; Levina, NV | 1 |
Kimura, Y; Matsumoto, T; Suzuki, M; Terashima, S | 1 |
1 review(s) available for daunorubicin and Leukemia P388
Article | Year |
---|---|
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
Topics: Animals; Antibiotics, Antineoplastic; Calcium Channel Blockers; Calmodulin; Carcinoma, Ehrlich Tumor; Daunorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Naphthacenes; Verapamil; Vinca Alkaloids; Vincristine | 1984 |
139 other study(ies) available for daunorubicin and Leukemia P388
Article | Year |
---|---|
Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Doxorubicin; Female; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1990 |
Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia L1210; Leukemia P388; Mice; Molecular Conformation | 1982 |
Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1982 |
New dimeric analogues of ethidium; synthesis, interaction with DNA, and antitumor activity.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; DNA, Neoplasm; Ethidium; Leukemia L1210; Leukemia P388; Melanoma; Mice; Neoplasms, Experimental; RNA, Neoplasm | 1981 |
6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Leukemia L1210; Leukemia P388; Mice; Pyrimidines; Structure-Activity Relationship | 1993 |
The Effectiveness of Cyclic Hydroxamic Acid CHA-5 against Drug-Resistant P388 Leukemia Strains.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Hydroxamic Acids; Leukemia P388; Mice; Survival Analysis; Vincristine | 2017 |
Activity of Antioxidant Enzymes and Content of Reduced Glutathione in Cells of Drug-Resistant Murine Leukemia P388 Strains.
Topics: Animals; Antineoplastic Agents; Antioxidants; Catalase; Cell Line, Tumor; Cisplatin; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Glutathione; Leukemia P388; Mice; Mice, Inbred DBA; Reactive Oxygen Species; Superoxide Dismutase | 2019 |
Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hyperthermia, Induced; Leukemia P388; Mice | 1989 |
Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium; Calcium Channel Blockers; Cell Line; Cells, Cultured; Daunorubicin; Drug Resistance; Ion Channels; Leukemia P388; Mice; Naphthacenes | 1984 |
Effects of ruthenium red on accumulation and cytotoxicity of m-AMSA, vinblastine and daunorubicin in leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Division; Cell Line; Daunorubicin; Leukemia P388; Leukemia, Experimental; Mice; Ruthenium; Ruthenium Red; Vinblastine | 1984 |
A new series of reductive amination derivatives of daunorubicin: syntheses, partition coefficients, and DNA binding.
Topics: Animals; Chemical Phenomena; Chemistry; Daunorubicin; DNA; DNA-Directed RNA Polymerases; Escherichia coli; Leukemia P388; Male; Mice; Solubility | 1984 |
[Effect of rubomycin and its paramagnetic analog on DNA synthesis].
Topics: Animals; Bone Marrow; Daunorubicin; DNA; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Heart; Leukemia P388; Mice; Myocardium | 1984 |
[In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Topics: Animals; Daunorubicin; Doxorubicin; Drug Resistance; In Vitro Techniques; Leukemia P388; Leukemia, Experimental; Methods; Mice; Mice, Inbred DBA; Time Factors | 1984 |
Total chemical synthesis and antitumor evaluation of 4-demethoxy-10,10-dimethyldaunomycin.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Idarubicin; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred DBA | 1984 |
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Topics: Animals; Biological Transport; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Trifluoperazine | 1984 |
[Colony-forming ability of bone marrow hematopoietic cells in mice with transplanted leukemia during administration of carminomycin].
Topics: Animals; Carubicin; Colony-Forming Units Assay; Daunorubicin; Female; Hematopoietic Stem Cells; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Rats | 1984 |
Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriers.
Topics: Animals; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Molecular Weight; Peptides; Polylysine | 1984 |
[Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
Topics: Animals; Daunorubicin; DNA, Neoplasm; Drug Evaluation, Preclinical; Leukemia P388; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred DBA; RNA, Neoplasm; Sarcoma 37; Sarcoma, Experimental | 1984 |
3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
Topics: Animals; Daunorubicin; Doxorubicin; Epirubicin; Leukemia P388; Mice; Structure-Activity Relationship | 1984 |
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1983 |
Mode of action of calcium antagonists which alter anthracycline resistance.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Mice; Naphthacenes; Nifedipine; Nitrendipine; Verapamil | 1984 |
Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Daunorubicin; Drug Resistance; Humans; Leukemia P388; Leukemia, Myeloid, Acute; Naphthacenes | 1984 |
Reversal of multidrug resistance by non-antitumor anthracycline analogs.
Topics: Animals; Antibiotics, Antineoplastic; Calcium Channel Blockers; Cells, Cultured; Daunorubicin; Drug Resistance; Drug Synergism; Leukemia P388; Naphthacenes; Vincristine | 1984 |
Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.
Topics: Animals; Cell Line; Daunorubicin; Dinitrophenols; Drug Resistance; Flow Cytometry; Leukemia P388; Leukemia, Experimental; Mice; Temperature | 1983 |
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Topics: Animals; Biological Transport; Cell Division; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Perhexiline; Vinblastine | 1984 |
Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells.
Topics: Animals; Daunorubicin; DNA, Neoplasm; Drug Resistance; Humans; Iodine Radioisotopes; Leukemia P388; Leukemia, Experimental; Lipoproteins, LDL; Mice; Spectrometry, Fluorescence | 1984 |
Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
Topics: Animals; Biological Transport; Cell Survival; Daunorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA; Verapamil | 1984 |
Characteristics of uptake and cytotoxicity of a low-density lipoprotein-daunomycin complex in P388 leukemic cells.
Topics: Animals; Binding, Competitive; Biological Transport; Cell Cycle; Cell Survival; Daunorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Lipoproteins, HDL; Lipoproteins, LDL; Mice | 1984 |
Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
Topics: Animals; Biological Transport; Daunorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA; Microscopy, Fluorescence | 1983 |
Antileukemic activity of 4-demethoxydaunorubicin in mice.
Topics: Administration, Oral; Animals; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Idarubicin; Injections, Intravenous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice | 1980 |
Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Glucosamine; Glycoproteins; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Tunicamycin | 1981 |
o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation, Preclinical; Leukemia P388; Methylation; Mice; Naphthacenes | 1982 |
Structure--activity relationships of nogalamycin analogues.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Mice; Nogalamycin; Structure-Activity Relationship | 1982 |
Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid.
Topics: Animals; Cell Survival; Daunorubicin; Doxorubicin; HeLa Cells; Humans; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Sarcoma, Experimental | 1982 |
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia P388; Mice | 1981 |
Effect of the methylation of aglycone hydroxyl groups on the biological and biochemical properties of daunorubicin.
Topics: Animals; Daunorubicin; HeLa Cells; Leukemia P388; Male; Methylation; Mice; Protein Binding | 1981 |
Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
Topics: Animals; Cells, Cultured; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Vincristine | 1981 |
Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.
Topics: Animals; Biological Transport; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Fabaceae; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Panax; Plants, Medicinal; Triterpenes; Tumor Cells, Cultured; Vinblastine | 1995 |
Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Coloring Agents; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia P388; Leukemia, Experimental; Leukemia, Myeloid; Membrane Glycoproteins; Mice; Naphthalenes; Polycyclic Compounds; Protein Kinase C; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1994 |
Role of protein kinase beta isozyme in multidrug resistance in murine leukemia P388/ADR cells.
Topics: Animals; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Isoenzymes; Leukemia P388; Mice; Protein Kinase C; Tumor Cells, Cultured | 1995 |
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; CHO Cells; Colchicine; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Membrane Glycoproteins; Tacrolimus; Tumor Cells, Cultured | 1993 |
Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cycloleucine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Leukemia P388; Mice; Microscopy, Fluorescence; Neoplasm Proteins; Oxygen; Photochemotherapy; Radiation-Sensitizing Agents; Rhodamine 123; Rhodamines; Singlet Oxygen; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1995 |
[Change in the chemotherapeutic sensitivity and cytogenetic characteristics during lengthy passage of tumors with the multidrug resistance phenotype and genotype].
Topics: Animals; Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Daunorubicin; Drug Resistance, Multiple; Genotype; Karyotyping; Leukemia P388; Phenotype; Vincristine | 1994 |
Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carrier Proteins; Daunorubicin; Drug Resistance; Gene Expression Regulation, Neoplastic; Hydrogen-Ion Concentration; Leukemia L1210; Leukemia P388; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1993 |
Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance; Extracellular Space; Leukemia P388; Membrane Glycoproteins; Mice; Molecular Sequence Data; Peptides, Cyclic; Verapamil | 1994 |
SDZ 280-125: a cyclopeptolide endowed with an in vitro cyclosporin A-like profile of activity for the reversion of the P-glycoprotein-mediated multidrug resistance of tumor cells.
Topics: Amino Acid Sequence; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Cricetinae; Cyclosporine; Daunorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Mice; Molecular Sequence Data; Neoplasms, Experimental; Peptides, Cyclic; Tumor Cells, Cultured | 1994 |
Fractionation of Cremophor EL delineates components responsible for plasma lipoprotein alterations and multidrug resistance reversal.
Topics: Animals; Antineoplastic Agents; Biological Transport; Chemical Fractionation; Chromatography, High Pressure Liquid; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Glycerol; Humans; Leukemia P388; Lipoproteins; Mice; Paclitaxel; Pharmaceutical Vehicles; Protein Binding | 1995 |
[14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Esters; Humans; Hydrazones; Leukemia P388; Tumor Cells, Cultured | 1995 |
Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
Topics: Adenocarcinoma; Alkaloids; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Colonic Neoplasms; Cricetinae; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia P388; Lung Neoplasms; Mice; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1996 |
[Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug Carriers; Leukemia P388; Liposomes; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred A; Mice, Inbred DBA; Platinum Compounds | 1996 |
Saturation reversal of the multidrug pump using many reversers in low-dose combinations.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Daunorubicin; Drug Resistance, Multiple; Kinetics; Leukemia P388; Tumor Cells, Cultured; Vinblastine | 1995 |
Reversal of P-glycoprotein is greatly reduced by the presence of plasma but can be monitored by an ex vivo clinical assay.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Drug Screening Assays, Antitumor; Humans; Kidney; Leukemia P388; Mice; Plasma; Quinidine; Verapamil; Vinblastine | 1996 |
Mutually co-operative interactions between modulators of P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Drug Synergism; Kinetics; Leukemia P388; Mefloquine; Tamoxifen; Tumor Cells, Cultured; Verapamil; Vinblastine | 1997 |
Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Line; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; HL-60 Cells; Humans; Leukemia P388; Mice; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Vincristine | 1997 |
Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Mice; Neoplasm Transplantation; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Ciprofloxacin; Daunorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Klebsiella Infections; Klebsiella pneumoniae; Leukemia P388; Leukocyte Count; Male; Mice; Mice, Inbred DBA; Naphthyridines; Neoplasm Transplantation; Pneumonia, Bacterial; Recombinant Proteins | 2000 |
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Topics: Animals; Antibiotics, Antineoplastic; CHO Cells; Cricetinae; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Tumor Cells, Cultured | 2001 |
7-(Aminoethyl) ether and thioether of daunomycinone.
Topics: Animals; Chemical Phenomena; Chemistry; Daunorubicin; Depression, Chemical; DNA; Leukemia L1210; Leukemia P388; Mice | 1979 |
Cellular accumulation and disposition of aclacinomycin A.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Nucleus; Cytoplasm; Daunorubicin; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Nucleic Acids | 1979 |
7-O-(3-Amino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)daunomycinone, a configurational analog of daunorubicin.
Topics: Animals; Carbohydrate Conformation; Daunorubicin; Leukemia P388; Methods; Mice | 1979 |
Rubomycin loaded erythrocytes in the treatment of mouse tumor P388.
Topics: Animals; Daunorubicin; Drug Carriers; Erythrocyte Membrane; Female; Leukemia P388; Mice; Mice, Inbred DBA | 1992 |
Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Daunorubicin; Drug Resistance; Flow Cytometry; Isoenzymes; Leukemia P388; Membrane Glycoproteins; Mice; Protein Kinase C; Tetradecanoylphorbol Acetate | 1992 |
Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance; Leukemia P388; Mice; Phosphates | 1992 |
Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells.
Topics: Animals; Biological Transport; Cell Membrane; Cell Membrane Permeability; Daunorubicin; Drug Resistance; Kinetics; Leukemia P388; Liposomes; Receptors, Drug; Receptors, Immunologic; Spectrometry, Fluorescence; Verapamil | 1992 |
Properties of cremophor EL micelles probed by fluorescence.
Topics: Anilino Naphthalenesulfonates; Animals; Biological Transport; Daunorubicin; Fluorescence Polarization; Fluorescent Dyes; Glycerol; Leukemia P388; Mice; Micelles; Spectrometry, Fluorescence; Surface-Active Agents; Tumor Cells, Cultured | 1992 |
Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance.
Topics: Animals; Cell Membrane; Daunorubicin; Drug Resistance; Freeze Fracturing; Leukemia P388; Membrane Glycoproteins; Mice; Phenotype; Tumor Cells, Cultured; Verapamil | 1992 |
Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells.
Topics: Animals; Cell Membrane; Daunorubicin; Drug Resistance; Energy Transfer; Fluorescence; Leukemia P388; Leukemia, Experimental; Mice; Tumor Cells, Cultured | 1992 |
Reversal of multidrug resistance by surfactants.
Topics: Animals; Biological Transport; Bone Marrow; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance; Glycerol; Humans; Leukemia P388; Membrane Fluidity; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Surface-Active Agents; Tumor Cells, Cultured | 1992 |
Newly formed chromosome-like structures in independent mouse P388 sublines with developed in vivo mdr1 gene amplification.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Banding; Chromosomes; Daunorubicin; Drug Resistance; Gene Amplification; Karyotyping; Leukemia P388; Membrane Glycoproteins; Mice; Tumor Cells, Cultured; Vincristine | 1991 |
[Features of developing resistance during combined use of antineoplastic agents, causing multiple drug resistance].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colchicine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Mice; Phenotype; Vincristine | 1991 |
Changes in the toxicity and therapeutic efficacy of daunorubicin linked with a biodegradable carrier.
Topics: Animals; Aza Compounds; Blood Pressure; Body Weight; Creatine Kinase; Daunorubicin; Drug Carriers; Drug Interactions; Female; Heart Rate; Injections, Intraperitoneal; Leukemia P388; Liver; Male; Mice; Mice, Inbred Strains; Nitriles; Peptides; Plasmacytoma; Pyrimidine Nucleosides; Sulfobromophthalein | 1991 |
Ultrastructural alterations in plasma membranes from drug-resistant P388 murine leukemia cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Daunorubicin; Drug Resistance; Exocytosis; Freeze Fracturing; Leukemia P388; Membrane Glycoproteins; Mice; Phenotype; Tumor Cells, Cultured | 1990 |
[Study of toxicity and antineoplastic activity of 14-substituted derivatives of rubomycin and carminomycin].
Topics: Animals; Carubicin; Daunorubicin; Drug Evaluation, Preclinical; Female; Leukemia P388; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasms, Experimental | 1990 |
Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
Topics: Animals; Carbon Dioxide; Carmustine; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance; Glucose; Glucuronosyltransferase; Leukemia P388; Leukemia, Experimental; Pentose Phosphate Pathway | 1990 |
[Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cisplatin; Cytidine Monophosphate; Cytosine Nucleotides; Daunorubicin; Doxorubicin; Drug Synergism; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Mice; Mice, Inbred DBA; Mitomycin; Mitomycins; Vincristine | 1990 |
[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Menogaril; Mice; Nogalamycin; Rats; Sarcoma, Yoshida | 1990 |
Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Base Sequence; Daunorubicin; DNA, Viral; Doxorubicin; Leukemia P388; Mice; Molecular Sequence Data; Molecular Structure; Simian virus 40; Stereoisomerism; Structure-Activity Relationship; Teniposide; Topoisomerase II Inhibitors | 1990 |
Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.
Topics: Animals; Antineoplastic Agents; Cell Membrane; Daunorubicin; Drug Resistance; Leukemia P388; Liposomes; Membrane Lipids; Mice; Phospholipids; Tumor Cells, Cultured | 1990 |
[Antineoplastic activity of combinations of cytostatics and dextran-ferrite administered to mice with leukemia P-388].
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Combinations; Fluorouracil; Iron-Dextran Complex; Leukemia P388; Melphalan; Methotrexate; Mice; Tegafur | 1990 |
Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Daunorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Mice; Stilbenes; Tumor Cells, Cultured; Vinca Alkaloids | 1990 |
[Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
Topics: Animals; Antineoplastic Agents; Daunorubicin; Drug Resistance; Hydrogen-Ion Concentration; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains | 1990 |
[Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia P388; Leukemia, Experimental; Male; Methylnitrosourea; Methylurea Compounds; Mice; Structure-Activity Relationship | 1990 |
Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.
Topics: Affinity Labels; Animals; Antibiotics, Antineoplastic; Cells, Cultured; Daunorubicin; DNA; Humans; Leukemia P388; Mice; Microscopy, Fluorescence; RNA; Thymidine; Uridine | 1986 |
Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.
Topics: Animals; Carubicin; Cell Survival; Daunorubicin; DNA Replication; Leukemia P388; Mice; Mutagenicity Tests; Naphthacenes; Nogalamycin; RNA; Structure-Activity Relationship | 1986 |
Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
Topics: Animals; Dactinomycin; Daunorubicin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Leukemia P388; Leukemia, Experimental; Liver Neoplasms, Experimental; Mice; Microscopy, Phase-Contrast; Nuclear Proteins; Nucleophosmin; Ribonucleoproteins; RNA | 1987 |
Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Daunorubicin; Dogs; Female; Injections, Intravenous; Leukemia P388; Macaca mulatta; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin; Species Specificity | 1989 |
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Survival; Daunorubicin; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Humans; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred A; Mice, Inbred DBA; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Carcinoma, Ehrlich Tumor; Cell Membrane; Daunorubicin; Drug Resistance; Freeze Fracturing; Leukemia P388; Leukemia, Experimental; Phenotype; Tumor Cells, Cultured | 1989 |
Exploring multidrug resistance using rhodamine 123.
Topics: Animals; Daunorubicin; Doxorubicin; Drug Resistance; Fluorescent Dyes; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Microscopy, Fluorescence; Rhodamine 123; Rhodamines; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1989 |
Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Flow Cytometry; Lasers; Leukemia P388; Leukemia, Experimental; Mice; Radioimmunoassay; Tumor Cells, Cultured | 1989 |
[Phosphorus-containing metabolites in the cells of anthracycline-resistant strains of leukemia P388].
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Phosphorus; Time Factors | 1989 |
Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia P388; Stereoisomerism; Structure-Activity Relationship | 1989 |
Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2.
Topics: Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Leukemia P388; Leukemia, Experimental; Rats; Structure-Activity Relationship | 1989 |
L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Female; Histidinol; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA | 1989 |
[Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice | 1989 |
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Leukemia, Experimental; Menogaril; Mice; Mitoxantrone; Naphthacenes; Nogalamycin; Trifluoperazine | 1985 |
Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Daunorubicin; Doxorubicin; Drug Resistance; Estrogen Antagonists; Kinetics; Leukemia P388; Mice; Naphthacenes; Nifedipine; Nitrendipine; Tamoxifen; Verapamil | 1986 |
Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Life Expectancy; Menogaril; Mice; Mice, Inbred Strains; Mitoxantrone; Nogalamycin | 1987 |
Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase.
Topics: Animals; Carubicin; Cell Division; Circular Dichroism; Cytochrome c Group; Cytochrome Reductases; Daunorubicin; Drug Stability; Horses; Hydrogen-Ion Concentration; Iron; Leukemia P388; Mice; Myocardium; NADH Dehydrogenase; Organometallic Compounds; Potentiometry; Spectrophotometry; Superoxides | 1985 |
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Topics: Animals; Anthracyclines; Anthraquinones; Carboplatin; Cisplatin; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Humans; Leukemia P388; Mice; Naphthacenes; Organoplatinum Compounds; Tumor Stem Cell Assay | 1988 |
Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cells, Cultured; Daunorubicin; Drug Resistance; Drug Synergism; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Vinca Alkaloids; Vincristine | 1986 |
Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Injections, Intraperitoneal; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1988 |
Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
Topics: Animals; Cell Membrane; Daunorubicin; Drug Resistance; Endocytosis; Exocytosis; Female; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Tumor Cells, Cultured; Verapamil | 1987 |
Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Pyrazoles; Pyrazolones; Time Factors; Tumor Cells, Cultured; Verapamil | 1987 |
Delivery of lipophilic drugs using lipoproteins.
Topics: Aging; Animals; Antibodies, Monoclonal; Cell Adhesion Molecules; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Drug Resistance; Leukemia P388; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Models, Molecular; Receptors, LDL; Receptors, Scavenger | 1987 |
Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Podophyllotoxin; Verapamil; Vincristine | 1986 |
Effects of cytochalasins and colchicine on the accumulation and retention of daunomycin and vincristine in drug resistant tumor cells.
Topics: Animals; Cell Line; Cell Survival; Colchicine; Cytochalasin B; Cytochalasin D; Cytochalasins; Daunorubicin; Drug Resistance; Humans; Leukemia; Leukemia P388; Leukemia, Myeloid, Acute; Mice; Verapamil; Vincristine | 1986 |
Flow cytometric monitoring of anthracycline transport in tumor cells.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Chlorpromazine; Daunorubicin; Flow Cytometry; Humans; Lasers; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Verapamil | 1986 |
Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport; Calcium Channel Blockers; Calmodulin; Cell Line; Daunorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Polysorbates; Pyrazoles; Quinidine; Solubility; Structure-Activity Relationship | 1986 |
Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Cross-Linking Reagents; Daunorubicin; DNA; DNA Damage; DNA, Neoplasm; Leukemia P388; Mice; Naphthacenes; Structure-Activity Relationship | 1986 |
Anthracycline photoaffinity labeling of a mitochondrial polypeptide in P388 murine leukemic cell lines.
Topics: Affinity Labels; Animals; Antibiotics, Antineoplastic; Carrier Proteins; Cell Line; Daunorubicin; Leukemia P388; Leukemia, Experimental; Mice; Mitochondria; Molecular Weight; Naphthacenes; Tritium | 1986 |
Biochemical mechanism for resistance to anthracycline antibiotics.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Daunorubicin; Drug Resistance; Leukemia P388; Naphthacenes; Vincristine | 1986 |
Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Nucleus; Daunorubicin; DNA; Doxorubicin; Idarubicin; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Nucleic Acid Conformation | 1987 |
[Models of preclinical studies of anthracyclines].
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice | 1987 |
Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
Topics: Animals; Daunorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Structure-Activity Relationship | 1986 |
[Characteristics of anthracycline-resistant strains of P388 leukemia].
Topics: Animals; Daunorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice | 1987 |
Inhibition of protein kinase C by antineoplastic agents: implications for drug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Kinetics; Leukemia P388; Mice; Protein Kinase C; Vinblastine; Vincristine | 1987 |
[Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA, Neoplasm; Drug Resistance; Gene Amplification; Genotype; Karyotyping; Leukemia P388; Leukemia, Experimental; Mice; Phenotype; Selection, Genetic; Tumor Cells, Cultured | 1987 |
Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
Topics: Animals; Cell Cycle; Cell Survival; Cells, Cultured; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Time Factors; Trifluoperazine | 1986 |
Effects of verapamil on in vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemia.
Topics: Acute Disease; Animals; Bone Marrow; Daunorubicin; Drug Resistance; Humans; In Vitro Techniques; Kinetics; Leukemia; Leukemia P388; Mice; Stimulation, Chemical; Verapamil | 1986 |
Cytostatic activity of daunorubicin analogs containing daunosamine as furanoside.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Spectrophotometry, Infrared | 1986 |
New N-amino acid derivatives of daunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Rats | 1986 |
7-Deoxydaunomycinone quinone methide reactivity with thiol nucleophiles.
Topics: Animals; Antineoplastic Agents; Circular Dichroism; Daunorubicin; Drug Evaluation, Preclinical; Ferredoxin-NADP Reductase; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; NADP; Naphthacenes; Plants; Spectrophotometry, Infrared; Structure-Activity Relationship; Sulfhydryl Compounds | 1986 |
New cyanomorpholinyl byproduct of doxorubicin reductive alkylation.
Topics: Alkylation; Animals; Daunorubicin; DNA Replication; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Oxidation-Reduction; Structure-Activity Relationship | 1986 |
Total chemical synthesis and antitumor evaluation of the 9-aza analogue of N-(trifluoroacetyl)-4-demethoxydaunomycin.
Topics: Animals; Antineoplastic Agents; Aza Compounds; Circular Dichroism; Daunorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 1986 |
Synthesis of 4-demethoxyanthracyclines carrying a lipophilic alkanoyl group at the C9-position.
Topics: Animals; Antineoplastic Agents; Cell Division; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia P388; Mice | 1986 |
Synthesis of novel 13-methyl-13-dihydroanthracyclines.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; Idarubicin; Leukemia P388; Mice | 1986 |
Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives.
Topics: Animals; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Stability; Esters; Hydrogen-Ion Concentration; Leukemia P388; Leukemia, Experimental; Male; Mice; Solubility; Water | 1985 |
Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry.
Topics: Adolescent; Adult; Aged; Animals; Bone Marrow; Daunorubicin; Doxorubicin; Female; Flow Cytometry; Humans; In Vitro Techniques; Lasers; Leukemia; Leukemia P388; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mice; Middle Aged | 1985 |
Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Topics: Animals; Antibiotics, Antineoplastic; Calcium; Calcium Channel Blockers; Cell Line; Daunorubicin; Drug Resistance; Egtazic Acid; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; RNA, Messenger | 1985 |
Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Topics: Animals; Biological Transport; Cell Line; Chlorpromazine; Daunorubicin; Doxorubicin; Flow Cytometry; Fluorometry; Leukemia P388; Leukemia, Experimental; Mice; Monitoring, Physiologic; Trifluoperazine; Tumor Stem Cell Assay; Verapamil | 1986 |
Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
Topics: Animals; Cardiolipins; Cell Division; Circular Dichroism; Daunorubicin; Doxorubicin; Hydrogen-Ion Concentration; Kinetics; Leukemia P388; Leukemia, Experimental; Liposomes; Male; Mice; Mice, Inbred Strains; NADH Dehydrogenase; Palladium; Phosphatidylcholines; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship | 1986 |
[Hemopoietic precursor cells during the development of carminomycin resistance].
Topics: Animals; Bone Marrow; Carubicin; Colony-Forming Units Assay; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Female; Hematopoietic Stem Cells; Leukemia P388; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1985 |
Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Tumor Stem Cell Assay | 1985 |
Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
Topics: Animals; Cell Line; Chemical Phenomena; Chemistry; Daunorubicin; Drug Resistance; Leukemia P388; Mice; Propylamines; Tiapamil Hydrochloride | 1985 |
Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Leukemia P388; Magnetic Resonance Spectroscopy; Mice | 1985 |
[Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
Topics: Animals; Antineoplastic Agents; Carubicin; Cell Survival; Daunorubicin; Drug Resistance; Female; Hematopoietic Stem Cells; Leukemia P388; Leukemia, Experimental; Mice; Mitosis; Neoplasm Transplantation | 1985 |
Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Idarubicin; Leukemia P388; Mice | 1985 |
Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 1985 |